Thomas H. Kean, Jr.

Each lead lines up three public records: a trade Thomas H. Kean, Jr. disclosed, a USAspending action on a contract with the same company within 90 days of it, and a seat on a committee that oversees or funds the agency involved. They are leads built from public records, not findings of wrongdoing.

• Bought ABT 49 days before HHS acted on a $65.5M contract

  Thomas H. Kean, Jr. (R-NJ) bought $1,001 - $15,000 of Abbott Laboratories (ABT) on January 29, 2026, according to a transaction report disclosed February 19, 2026. USAspending records an action by the Department of Health and Human Services on March 19, 2026, 49 days after the nearest trade, on a definitive contract (75A50122C00046) with Abbott Laboratories whose total value is $65.5M. Kean sits on the House Committee on Energy and Commerce, which oversees the Department of Health and Human Services. March 19, 2026 was the latest action USAspending listed for that contract when it was pulled on June 19, 2026; the contract itself may be years older, and $65.5M is its total value, not the amount of that action. The records do not show who placed the trade or that anyone involved knew of the contract.

Recent Votes (20)